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A C C E P T E D M
A N U S C R I P T A C C E P T E D M A N U S C R I P T be crucial to prevent ICH brain injury. Here, we report that the expression of transient receptor potential vanilloid 4 (TRPV4) was upregulated in mouse neurons after ICH. The selective TRPV4 agonist GSK1016790A aggravated neuronal death whereas the TRPV4 antagonist HC-067047 promoted neuronal survival after ICH. We found that GSK1016790A
triggered Ca 2+ signals that were amplified and propagated by Ca 2+ -induced Ca 2+ release (CICR) from the endoplasmic reticulum (ER) in the neurons. ICH recruited inositol triphosphate receptors (IP3Rs) into the TRPV4 protein complex, which positively regulated the activity of TRPV4 channels. Excessive activation of TRPV4 channels destroyed Ca 2+ homeostasis and induced ER unfolded protein response (UPR). Blocking TRPV4 receptors decreased UPR，inhibited the PERK-CHOP-Bcl-2 signaling pathway and increased neuron survival. Overall, these results suggested that overactivation of TRPV4 channels after ICH ledto the destruction of Ca 2+ homeostasis, which in turn caused UPR and neural apoptosis.
Inhibition of TRPV4 channels is a promising therapy to promote neurons recover, and to ameliorate disability after ICH. Transient receptor potential vanilloid 4 (TRPV4), a member of the transient receptor potential superfamily, is broadly expressed in the central nervous system (Kanju and Liedtke, 2016) . The human TRPV4 gene is located on chromosome 12q23-24.1 (Liedtke et al., 2000) .
TRPV4 channels can be activated by a variety of stimuli, such as moderate temperature, mechanical stimulation, cell swelling, and epoxyeicosatrienoic acids and endocannabinoids (Vriens et al., 2004) . TRPV4 channels bring out an influx of Ca 2+ with theirs activation under physiological conditions, which may be involved in the regulation of cell volume (Becker et al., 2005) , the integrity of the blood-cerebrospinal fluid barrier (Narita et al., 2015) , the excitability of neurons (Shibasaki et al., 2015) , and the tension of cerebral vessels (Earley et al., 2005) . TRPV4 channels also participate in a series of pathophysiological processes including neuronal apoptosis induced by ischemia and hypoxia (Jie et al., 2015) , inflammatory response induced by acute lung injury (Balakrishna et al., 2014) , and brain edema induced by traumatic brain injury (Lu et al., 2017) . Recently, it has been reported that it also exerts an effect in intracerebral hemorrhage (Zhao et al., 2018) .
The endoplasmic reticulum (ER) is a large calcium store within a cell. ER stress could occur when there is an overload of protein synthesis, protein misfolding or depletion of Ca 2+ storage (Xu et al., 2005) . To deal with ER stress, the unfolded protein response (UPR) is activated to alleviate ER stress and improve cell survival (Hiramatsu et al., 2015) . However,
prolonged activation of UPR causes destruction of calcium hemostasis and brings about programmed cell death (Richter et al., 2016; Chao et al., 2012 (Dunn et al., 2013; Ryskamp et al., 2011; Jo et al., 2015) . TRPV4-mediated Ca 2+ influx contributes to the endfoot Ca 2+ response to neuronal activation (Dunn et al., 2013) , to apoptosis of mouse retinal ganglion cells (Ryskamp et al., 2011) , and to cell volume regulation (Jo et al., 2015) . We thus considered whether TRPV4
could influence Ca 2+ homeostasis of the endoplasmic reticulumand then induce neuron apoptosis after ICH.
In the present study, we investigated whether TRPV4 channels exerted a function, and the mechanism behind this function, in autologous blood infusion mouse models of ICH. Our findings showed that the expression level of TRPV4 is upregulated in mouse neurons after ICH. Inhibition of TRPV4 channels improves neuronal survival. The activation of TRPV4 leads to the disturbance of Ca 2+ homeostasis, which in turn gives rise to UPR and neural apoptosis after ICH. Our data suggest that TRPV4 is involved in the development of brain injury after ICH, implicating TRPV4 as a new therapeutic target for the treatment of hemorrhagic brain injury.
Materials and Methods

Animal experiments
All of the animal experiments were approved by the ethical guidelines of the Chongqing Medical University Animal Research Committee, and complied with the NIH Guide for the
Care and Use of Laboratory Animals. In all of the experiments, animals were randomly assigned to groups. All of the behavioral and histological analyses were performed by an experimenter blinded to the identity of the groups. ICH models were induced by autologous blood infusion in male C57BL/6J mice (8~13 weeks of age, 18-25g-25 g). We established mouse ICH models using a double injection method (Deinsberger et al., 1996) . After intraperitoneal injection of 38 mg/kg chloral hydrate, mice were positioned prone and placed in a stereotaxic frame. A burr hole was drilled in the right parietal bone of the skull (2.0 mm lateral to the midline, 0.4 mm anterior to the bregma). The mixed (arterial and venous) blood was collected by cutting the tip of the tail and then quickly transferred it into a 50-μl glass syringe. The needle was inserted through the burr hole and advanced 3.5 mm below the skull.
After 5 μl autologous blood was injected, the injection was terminated five minutes. The needle was then lowered to 4.0 mm in depth, and 25 μl autologous blood was injected into the right striatum (Krafft et al., 2014) . Sham animals were subjected to the same manipulations as the ICH mice, but no blood was injected.
The drugs (GSK1016790A, HC-067047, 2-APB, thapsigargin, SKF96365) were dissolved in DMSO (Sigma, D8418), and the final diluted concentration of DMSO was less than 0.1% when used. GSK1016790A and HC-067047 were injected immediately into the lateral ventricle (stereotaxic coordinates: 1.0 mm lateral to the midline, 0.3 mm posterior to the bregma, and 2.5 mm below the skull) after operation. 2-APB was applied through intracerebroventricular injection 1 hour before surgery. Except for special hints, both GSK1016790A and HC-067047 were injected immediately into lateral ventricle after ICH.
Behavioral tests
Neurological and sensorimotor functions were evaluated via the neurological deficit scoring system and rope grip test at 24 hours after surgery.
In the neurological deficit scoring system, mice were scored using the composite Garcia neuroscore (Krafft et al., 2014) . The tests included spontaneous activity, axial sensation, vibrissae proprioception, symmetry of limb movement, lateral turning, forelimb outstretching, and climbing. The final neuroscore is the sum of the seven individual test scores. The minimum score is 3 and the maximum is 21.
In the rope grip test (Munakata et al., 2013) , mice were placed midway on a string between 2 supports and rated as follows: 0, falls off; 1, hangs onto string by one or both forepaws; 2, same as for 1, but attempts to climb onto string; 3, hangs onto string by one or both forepaws plus one or both hindpaws; 4, hangs onto string by forepaws and hindpaws plus tail wrapped around string; and 5 escapes to the supports. The final score was the average of 5 trials.
Evaluation of brain water content
Brain water content was measured via the wet weight/dry weight method. Mice were anesthetized with 3.8% chloral hydrate and killed at 24 hours after surgery. Ipsilateral brain tissues were separated and weighed in order to obtain the wet weight. The brain tissues were then dried at 100℃ for 24 hours and weighed to obtain the dry weight. Brain water content (%) was calculated as (wet weight -dry weight)/wet weight × 100% (Krafft et al., 2014) .
Immunohistochemistry and TUNEL staining
After 3.8% chloral hydrate intraperitoneal anesthesia, the animals were perfused with 0.9% saline and 4% paraformaldehyde in the left ventricle; the brains were rapidly removed and embedded in the paraffin. Coronal paraffin sections were made, and immunohistochemistry Fluorescence analysis and cell count were performed using Image J software.
Cell cultures
Brain tissues were isolated from the E17 mice. Cells were dissociated using 0.125% trypsin (Gibco, 13824) and planted with the densities of 100-150 cells/mm on glass-bottom dishes for Ca 2+ imaging. Cells were placed in fresh serum-free Neurobasal medium (Gibco, 21103) plus 2% B27 (Gibco, 17504), fed every 4 days with fresh media, and used for Ca 2+ imaging after 10 days.
Ca 2+ imaging
Neurons were washed twice with HBSS (Gibco, 14175) and then loaded with fluo-3 AM by incubation in HBSS for 30 min at 37℃. After that, the cells were washed twice and perfused with extracellular fluid (140 mM NaCl, 5 mM KCl, 1 mM MgCl2·6H2O, 2 mM CaCl2 , 10 mM D-glucose, 10 mM HEPES, pH 7.4). The [Ca 2+ ]i levels were examined under a Nikon-A1R microscope. Analysis of single-cell integrated signal density was performed on computers running NIH Image software (NIS 4.3).
Co-IP and Western blots
The perihematoma brain tissues were homogenized and split in ice-cold lysis buffer containing (mM): 50 Tris-HCl (pH7.4), 150 NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 2 EDTA, 1 sodium orthovanadate, and 1 phenylmethanesulfonyl fluoride. After centrifuging at 12,000 × g at 4°C, protein concentration in the extracts was determined by BCA protein assay (Beyotime, P0010).
For the coimmunoprecipitation，the perihematoma brain tissues were split in a mild lysis buffer containing (mM): 20 Tris-HCl (pH7.5), 150 NaCl, 1% Triton X-100, 1% sodium pyrophosphate, 2 EDTA, 1 Na3VO4, and 1 phenylmethanesulfonyl fluoride (Beyotime, P0013). The extracts (~1 mg protein) were incubated with nonspecitic IgG (1 μg) or polyclonal rabbit anti-TRPV4 (1 μg, Alomone Labs ， acc-034) or anti-IP3R (1 μg, Abcam,ab190239) overnight at 4°C, followed by the addition of 40 μl protein A/G agarose for 3 hours at 4°C. The precipitates were washed 4 times with lysis buffer and denatured with SDS sample buffer.
The samples were separated by 8% SDS-PAGE and transferred to polyvinylidene difluoride membranes. The transfer membranes were incubated with 5% nonfat dried milk dissolved in TBST, and then incubated overnight at 4°C with the primary antibodies. Membranes were washed three times with TBST buffer and incubated with the appropriate secondary antibodies for 2 hours. The protein bands were detected by enhanced chemiluminescence (Millipore, WBKLS0500). The gray value of the bands was determined using Image J software (IBM).
Antibodies and reagents
The following antibodies were used: TRPV4 (Abcam, ab39260), GRP78 (Cell Signaling (Sigma, S7809), GSK1016790A (Sigma, G0798), HC-067047 (Sigma, SML0143), and 2-APB (Tocris, 1224).
Statistical analysis
All of the data were presented as mean ± SD. Data analysis was performed using SPSS 19 (IBM). Graph drawing was performed using Prism 6. Statistical comparisons were made using one-way ANOVA following LSD post hoc test, paired-samples t test or independent-samples t Test. Differences in the mean values were considered to be significant at P < 0.05.
Results
The TRPV4 protein in the ipsilateral brain tissues was specifically upregulated after intracerebral hemorrhage
We examined the protein levels of TRPV4 in a mouse model of intracerebral hemorrhage induced by autologous blood infusion. The protein levels of TRPV4 in the ipsilateral brain tissues after ICH were gradually increased (Fig. 1A ) compared with those in the sham group.
The expression of TRPV4 protein was gradually increased from 6 hours after ICH, reached the highest level at 12 hours and remained stable for up to 24 hours (Fig. 1B) . There was no significant difference in the expression of TRPV4 protein between 12 hours and 24 hours.
TRPV4 protein expression gradually decreased to a nearly normal level at 48 hours to 72
hours after ICH. In addition, TRPV4 immunoreactivity in the ipsilateral brain tissues at 24 hours after ICH was markedly increased compared with thosethat in the sham group (Fig. 1C) .
At the same time, we observed a decrease of neurons in the ICH group compared with the sham group (Fig. 1D ). This suggested that neuronal injury could be related to the upregulation of TRPV4 expression.
Effect of TRPV4 on neurological deficits in the autologous blood infusion ICH model
To evaluate whether TRPV4 channels have a role in brain injury after ICH, GSK1016790A (a selective TRPV4 agonist, 0.1 μM, 0.3 μM,1 μM, 3 μM/2μL) or HC-067047 (a selective TRPV4 antagonist, 0.1 μM, 0.3 μM, 1 μM, 3 μM/2μL) was administered to the lateral ventricle after operation. The evaluation of the behavioral performance was carried on at 24
hours after ICH. The composite Garcia neuroscore, indicated that GSK1016790A aggravated the neurological deficiency, but HC-067047 improved it in a concentration-dependent manner ( Fig. 2A) . Similarly, the rope grip score was lower in the GSK1016790A-treated group than in the vehicle group, but was higher in the HC-067047-treated group than in the vehicle group (Fig. 2B ). In addition, we examined the effect of delayed HC-067047 treatment after ICH (Fig.   2C ). We administered HC-067047 intracerebroventricularly at 2 h, 6 h and 12 h. Neurological function tests were performed at 24 h after ICH. The results showed that treatment with HC-067047 at 2 h and 6 h after ICH was effective. However, there was no effect when HC-067047 was administered at 12 h after ICH.
TRPV4 inhibition improved the brain edema after intracerebral hemorrhage
After the ICH model was established, 1 μM GSK1016790A or 3 μM HC-067047 was
immediately administered through the lateral ventricle. Brain morphological changes in the perihematoma brain tissues at 24 h after ICH were detected using hematoxylin and eosin (HE).
In the sham-operated group, the structure of mouse brain tissue was clear and complete, the nucleus was clear and the nucleolus was centered. The gap around the cells was small. There was an obvious brain edema at 24 h after ICH, which was identified by the dissolved nuclei and vacuolar degeneration of cells, and by the widened intercellular space along with interstitial edema. The brain edema was clearly aggravated in the GSK1016790A-treated group, which was characterized by the enlarged area of edema and increased number of vacuolar degeneration cells. On the contrary, HC-067047 relieved brain edema and recovered the number of vacuolar degeneration cells (Fig. 3A ).
Brain edema was measured via the wet weight/dry weight method 24 h after ICH. The water content of brain tissue increased after ICH vs the sham group. The water content of brain tissue increased significantly in the GSK1016790A-treated group, and decreased in the HC-067047-treated group (Fig. 3B) .
Blockage of TRPV4 channels improved neuronal apoptosis at 24 h after intracerebral hemorrhage
As a neural characteristic structure, the number of Nissl bodies reflects the state of neurons. In the sham-operated group, the Nissl bodies were abundant, showing that the function of neuronal protein synthesis was strong. A large number of neuronal cells showed a decrease in Nissl bodies, which was identified by the cells dyed light in the vehicle group, indicating that neuronal cells were damaged. In the GSK1016790A-treated group (1 μM), the number of Nissl bodies was reduced or even disappeared, and some neurons formed vacuoles, indicating
that neuronal apoptosis increased. On the contrary, by blocking TRPV4 channels, HC-067047 (3 μM) could recover the number of Nissl bodies, indicating that neuronal apoptosis was improved (Fig. 4A) . The quantification of Nissl staining also showed that HC-067047 (3 μM) treatment recovered the number of Nissl bodies (Fig. 4B) .
We examined the apoptosis of neurons at 24 h after ICH by double staining with NeuN and TUNEL labeling (Fig. 4C) . The proportion of TUNEL-positive cells increased to 61.69% ± 2.79% after ICH. The proportion of TUNEL-positive cells increased further to 86.08% ± 4.15%
in the GSK1016790A-treated group. When TRPV4 channels were blocked by HC-067047, the TUNEL-positive cell rate dropped to 27.69% ± 2.68% (Fig. 4D) . (Fig. 5A, B) . The results showed that the intracellular calcium fluorescence intensity increased significantly after TRPV4 channels were activated (Fig. 5C ).
Activation of TRPV4 channels triggered
To confirm the Ca 2+ signals amplified by the release of Ca 2+ from internal stores, we depleted endoplasmic reticulum Ca 2+ stores in the control group by opening IP3 gated channels with thapsigargin (10 μM); in addition, we blocked potentiation channels with SKF 96365 (20 μM) in order to prevent Ca 2+ replenishment. Under these conditions, GSK1016790A (1 μM) failed to further increase calcium concentration, but produced a
slightly elevated background level of Ca 2+ -induced fluorescence (Fig. 5D, E, F) . These results suggest that TRPV4 channels trigger Ca 2+ release from the endoplasmic reticulum.
We next detected whether Ca 2+ release from the endoplasmic reticulum was triggered by Ca 2+ entering the neurons through open TRPV4 channels. When loaded with fluo-3 AM in extracellular solution without Ca 2+ , the neurons displayed only low baseline fluorescence.
After Ca 2+ was added again, the intracellular Ca 2+ concentration increased immediately (Fig.   5G, H, I ).
Intracerebral hemorrhage recruits IP3Rs into TRPV4 protein complex
To explore whether IP3Rs can combine with TRPV4 channels, we used an anti-IP3R antibody to precipitate the IP3R complex in the extracts from the ipsilateral brain tissues that had been subjected to ICH or sham operation. The precipitates from both groups were separated on the SDS-PAGE. The antibody against TRPV4 (Abcam, ab39260) probed the precipitates and made ensured the existence of endogenous TRPV4 in the IP3R complex (Fig. 6A) . We also carried out the reciprocal coimmunoprecipitation, in which the antibody against IP3R was used to precipitate TRPV4 (Fig. 6B) . The results showed that IP3Rs was physically associated with TRPV4 receptors, and ICH promoted the IP3Rs binding with TRPV4 receptors.
Neuronal apoptosis induced by ICH was associated with activation of the PERK-CHOP-Bcl-2 pathway
We examined whether TRPV4 channels induced ER stress after ICH. Indeed, we found that ICH induced a UPR, which was clearly evidenced by increased expression of GRP78, p-PERK, and CHOP, along with decreased expression of Bcl-2. Activating TRPV4 channels by GSK1016790A increased phospho-PERK and its downstream effector CHOP. In contrast,
blocking of TRPV4 channels by HC-067047 led to a decreased UPR and inhibited the expression of CHOP (Fig. 7A, B) . We also detected the expression of the IRE1-JNK pathway.
The results indicated a change in p-IRE1, but no change in the expression of p-JNK (Fig. 7C,   D ).
IP3R inhibition relieved endoplasmic reticulum stress and improved hemorrhagic brain injury
To confirm that IP3Rs influenced the function of TRPV4 after ICH, we administrated 10 μM 2-APB (an antagonist of IP3R) through the lateral ventricle at 1 h before ICH. GSK1016790A
(1 μM) or HC-067047 (3 μM) was injected into the lateral ventricle after operation, and then the ipsilateral brain tissues were extracted for immunoblotting at 24 h after ICH. The results showed that application of 2-APB alone could inhibit the activation of CHOP, but combined application of HC-067047 and 2-APB exerted a better effect on relieving endoplasmic reticulum stress (Fig. 8) .
Discussion
TRPV4 channels are widely distributed in the central nervous system (Kanju and Liedtke, 2016) . It has been reported that activated TRPV4 channels participate in multiple pathophysiological processes, such as Aβ40-induced hippocampal cell death (Bai and Lipsi, 2014) , cerebral hypoxia/ischemia (Butenko et al., 2012) , and the apoptosis of mouse retinal ganglion cells (Ryskamp et al., 2011) .
Our investigations demonstrated that the expression of TRPV4 protein was upregulated after ICH by immunoblotting and immunofluorescence. Consistent with our study, other research has suggested that TRPV4 proteins are increased after traumatic brain injury (Lu et al., 2017) ,
in a rat middle cerebral artery occlusion model (Jie et al., 2015) , and in cortical lesions of patients with focal cortical dysplasia (Chen et al., 2016) . Furthermore, TRPV4 protein was found to be increased in aged rats compared with young rats, which may be associated with neurodegenerative diseases (Lee and Choe, 2014) . This indicates that the TRPV4 channel, as an osmotic sensor, mechanical stimuli sensor, and chemical sensor (Liedtke et al., 2000; Liedtke and Kim, 2005; Moore et al., 2018; Ciura et al., 2018; Mizuno et al., 2003; Suzuki et al., 2013; Ryskamp et al., 2014) , can sense changes in the internal environment and adjust its expression. Our results also showed that inhibition of TRPV4 channels contributed to the alleviation of ICH-induced brain edema, the suppression of neuronal apoptosis, and the improvement of mouse neurological function.
Hence, TRPV4 inhibition may constitute a novel therapeutic target for ICH. We also noticed that the blockage of TRPV4 was invalid when ICH happened more than 12 h. Since the period from 12h to 24h after ICH is a period in which pathophysiological changes become aggravated, the results suggest that inhibition of TRPV4 as soon as possible after ICH can exert a better effect.
It has been demonstrated that cell swelling, eicosanoid metabolites, and mechanical stimulation can activate TRPV4 channels (Virens et al., 2004; Ryskampet al., 2014) . As is known, intracerebral hemorrhage can cause brain edema and cell swelling. Thus, cell swelling may be an activator of TRPV4. The other endogenous activator of TRPV4 may be anandamide. The endocannabinoid anandamide activates TRPV4 via the formation of 5,6-EET (Watanabe, et al., 2003) . It has been shown that anandamide content is increased after stroke (Muthian, et al., 2004) . Therefore, we believe the above two factors may activate
the TRPV4 channels after ICH.
Some researchers found that activated TRPV4 channels mainly mediated the influx of Ca 2+ ions, and formed calcium oscillation in the cells (Dunn, et al., 2013; Liedtke et al., 2000; Suzuki et al., 2013; Ryskamp, et al., 2011) . Our research also confirmed that GSK1016790A， homeostasis, the flow of Ca 2+ into and out of the endoplasmic reticulum has to be precisely regulated to be in balance (Krebs et al., 2015) . Ca 2+ ions are released through inositol-1,4,5-trisphosphate receptors (IP3Rs) located on the membrane of the ER and recycled by Ca 2+ pumps of the ER, which use ATP as an energy source to pump Ca 2+ against a steep ion gradient across the membrane. We believe that the factors that follow may result in activation after ICH. It has been found that TRPV4 has a site binding to the IP3Rs within the second ANK domain at the C-tail (aa 812-831), and IP3Rs are positive modulators of TRPV4 channel activity (Fernandes et al., 2008; Garcia-Elias et al., 2008) . In the present study, we demonstrated that ICH recruits IP3Rs into the TRPV4 protein complex by coimmunoprecipitation, which may cause the sustained activation of TRPV4 channels, and result in an enhanced CICR response, finally give rising to chronically prolonged depletion of ER Ca 2+ ions.
Depletion of Ca 2+ store leads to a rapid accumulation of misfolded proteins and promotes dissociation of GRP78 from PERK, IRE1 and ATF6, thereby activating the UPR pathway (Krebs et al., 2015) . The UPR prevents further accumulation of newly synthesized proteins in the ER for the sake of reducing further burden to the ER. However, prolonged UPR activation occurs when normal ER function fails to be restored, which then causes ER stress and cell apoptosis (Ryu et al., 2002) . PERK is a key protein responsible for ER stress. The phosphorylation of PERK induces the apoptosis-relevant transcriptional factor CHOP and then activates the mitochondrial apoptosis pathway (McCullough et al., 2001; Marciniak et al., 2004) . IRE1 is another transmembrane protein that is located in the membrane of the ER.
Prolonged ER stress also stimulates the phosphorylation of IRE1, which causes downstream
activation of stress kinase Jun-N-terminal kinase (JNK), which promote apoptosis (Urano et al., 2000; Nishitoh et al., 2002) . In the present study, we observed that ICH increased PERK activation by increasing cellular levels of phosphorylated PERK, which in turn upregulated CHOP expression and inhibited the expression of Bcl-2. These results are consistent with previous studies indicating that UPR triggered cell apoptosis through the PERK-CHOP-Bcl-2 pathway (McCullough et al., 2001; Marciniak et al., 2004) . We found that inhibition of IP3Rs by 2-APB could relieve ER stress. This implies that IP3Rs regulate the activation of TRPV4 channels after ICH. However, it was interesting that phosphorylation of IRE1 increased but phosphorylation of JNK did not change after ICH. This may be caused by activation of IRE1 involving activation of p38 MAPK, which in turn activates CHOP (Wang and Ron, 1996) .
Other evidence also supports our results. For example, TRPC3, a member of the TRP superfamily, mediates the Ca 2+ influx that is necessary for ER stress-induced apoptosis (Ampem et al., 2016) . Furthermore, activation of transient receptor potential vanilloid 1 results in ER stress and cell death in human lung cells (Tomas et al., 2007 ).
In conclusion, our results suggest that ICH causes upregulation of TRPV4 channels and recruitment of IP3Rs, which results in an enhanced CICR response, and finally leads to the depletion of ER Ca2+ ions. Disruption of ER Ca2+ homeostasis activates the PERK-CHOP-Bcl-2 pathway and induces neuronal apoptosis. Therefore, the present study highlights the mechanisms of TRPV4 in ICH-induced neuronal apoptosis and supplies a novel target of neuroprotection with ICH. In future work, we will use TRPV4 knockout mice or TRPV4 gene silencing mice to verify our experimental results. Furthermore, GSK2193874, an orally active and selective blocker of TRPV4, has been shown to resolve pulmonary edema
induced by heart failure (Thorneloe et al., 2012) . We will test the effectiveness of GSK2193874 in a mouse model of intracerebral hemorrhage so as to promote the clinical application of TRPV4 channel blockers.
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